alarm-ringing ambulance angle2 archive arrow-down arrow-left arrow-right arrow-up at-sign baby baby2 bag binoculars book-open book2 bookmark2 bubble calendar-check calendar-empty camera2 cart chart-growth check chevron-down chevron-left chevron-right chevron-up circle-minus circle city clapboard-play clipboard-empty clipboard-text clock clock2 cloud-download cloud-windy cloud clubs cog cross crown cube youtube diamond4 diamonds drop-crossed drop2 earth ellipsis envelope-open envelope exclamation eye-dropper eye facebook file-empty fire flag2 flare foursquare gift glasses google graph hammer-wrench heart-pulse heart home instagram joystick lamp layers lifebuoy link linkedin list lock magic-wand map-marker map medal-empty menu microscope minus moon mustache-glasses paper-plane paperclip papers pen pencil pie-chart pinterest plus-circle plus power pushpin question rain reading receipt recycle reminder sad shield-check smartphone smile soccer spades speed-medium spotlights star-empty star-half star store sun-glasses sun tag telephone thumbs-down thumbs-up tree tumblr twitter user users wheelchair write yelp youtube

FDA Approves Implantable Telescope To Help Patients With Age-Related Macular Degeneration.

The AP (7/7, Neergaard) reports that the FDA has “approved a first-of-its-kind technology to counter a leading cause of blindness in older adults — a tiny telescope implanted inside the eye.” The Implantable Miniature Telescope “aims to help in the end stages of incurable age-related macular degeneration,” although the FDA “warned Tuesday that patients need post-surgery rehabilitation to make it work.” Dr. Malvina Eydelman, FDA’s ophthalmic devices chief, said the device can improve the quality of life for those who are 75 and older, have a certain degree of vision loss and who also need a cataract removed. In addition, “the FDA took the highly unusual step of requiring that patients and their surgeons sign a detailed ‘acceptance of risk agreement’ before surgery, acknowledging potential side effects — including corneal damage and worsened vision — and the need for lots of testing to determine who’s a candidate.”
The San Jose Mercury News (7/7, Johnson) notes, “In a study involving more than 200 patients implanted with the device, the FDA said, 75 percent ‘improved their level of vision from severe or profound impairment to moderate impairment.'” NPR’s (7/6, James) “Two-Way” blog also covered the story.